NCT01549015 - Study in Healthy Subjects, Patients With Urea Cycle Disorders (UCD) and Carriers of UCD Mutations to Evaluate Urea Cycle Function | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

March 31, 2013

Conditions

Urea Cycle Disorders

Interventions

OTHER

oral administration of Sodium [1,2-13C]-Acetate

single dose of 0.55 mg/kg 13C-Acetate given orally of via a naso-gastric tube

Trial Locations (4)

Medizinische Hochschule Hannover, Klinik für Kinderheilkunde, Hanover

CRS Clinical Research Services GmbH (Phase I Unit)

Universitätsklinikum Münster, Zentrum für Kinder- und Jugendmedizin, Münster

Universitätsklinikum Heidelberg Klinik für Kinderheilkunde I, Heidelberg